| Expression of transcription factor E2F1 induces quiescent cells to enter S phase DG Johnson, JK Schwarz, WD Cress, JR Nevins Nature 365 (6444), 349-352, 1993 | 1279 | 1993 |
| Histone deacetylases, transcriptional control, and cancer WD Cress, E Seto Journal of cellular physiology 184 (1), 1-16, 2000 | 897 | 2000 |
| Critical structural elements of the VP16 transcriptional activation domain WD Cress, SJ Triezenberg Science 251 (4989), 87-90, 1991 | 576 | 1991 |
| Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage C Wang, L Chen, X Hou, Z Li, N Kabra, Y Ma, S Nemoto, T Finkel, W Gu, ... Nature cell biology 8 (9), 1025-1031, 2006 | 540 | 2006 |
| Role of Stat3 in regulating p53 expression and function G Niu, KL Wright, Y Ma, GM Wright, M Huang, R Irby, J Briggs, J Karras, ... Molecular and cellular biology 25 (17), 7432-7440, 2005 | 489 | 2005 |
| Reduced binding of TFIID to transcriptionally compromised mutants of VP16 CJ Ingles, M Shales, WD Cress, SJ Triezenberg, J Greenblatt Nature 351 (6327), 588-590, 1991 | 403 | 1991 |
| Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors SL Berger, WD Cress, A Cress, SJ Triezenberg, L Guarente Cell 61 (7), 1199-1208, 1990 | 400 | 1990 |
| Oncogenic capacity of the E2F1 gene. DG Johnson, WD Cress, L Jakoi, JR Nevins Proceedings of the National Academy of Sciences 91 (26), 12823-12827, 1994 | 358 | 1994 |
| Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma MB Schabath, EA Welsh, WJ Fulp, L Chen, JK Teer, ZJ Thompson, ... Oncogene 35 (24), 3209-3216, 2016 | 290 | 2016 |
| Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells L Song, D Coppola, S Livingston, WD Cress, EB Haura Cancer biology & therapy 4 (3), 267-276, 2005 | 275 | 2005 |
| Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells G Niu, J Briggs, J Deng, Y Ma, H Lee, M Kortylewski, M Kujawski, H Kay, ... Molecular Cancer Research 6 (7), 1099-1105, 2008 | 236 | 2008 |
| TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells SS Donatelli, JM Zhou, DL Gilvary, EA Eksioglu, X Chen, WD Cress, ... Proceedings of the National Academy of Sciences 111 (11), 4203-4208, 2014 | 215 | 2014 |
| CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 H Chen, C Li, J Huang, T Cung, K Seiss, J Beamon, MF Carrington, ... The Journal of clinical investigation 121 (4), 1549-1560, 2011 | 207 | 2011 |
| cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth Z Chen, JL Li, S Lin, C Cao, NT Gimbrone, R Yang, DA Fu, MB Carper, ... The Journal of clinical investigation 126 (6), 2267-2279, 2016 | 197 | 2016 |
| Direct repression of the Mcl-1 promoter by E2F1 R Croxton, Y Ma, L Song, EB Haura, WD Cress Oncogene 21 (9), 1359-1369, 2002 | 191 | 2002 |
| Subunit composition determines E2F DNA-binding site specificity Y Tao, RF Kassatly, WD Cress, JM Horowitz Molecular and cellular biology, 1997 | 172 | 1997 |
| Deregulated expression of LRBA facilitates cancer cell growth JW Wang, JJ Gamsby, SL Highfill, LB Mora, GC Bloom, TJ Yeatman, ... Oncogene 23 (23), 4089-4097, 2004 | 162 | 2004 |
| A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4 WD Cress, DG Johnson, JR Nevins Molecular and cellular biology 13 (10), 6314-6325, 1993 | 158 | 1993 |
| Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1 Y Ma, WD Cress, EB Haura Molecular cancer therapeutics 2 (1), 73-81, 2003 | 132 | 2003 |
| Identification of novel E2F1-regulated genes by microarray Y Ma, R Croxton, RL Moorer Jr, WD Cress Archives of biochemistry and biophysics 399 (2), 212-224, 2002 | 132 | 2002 |
